BioCentury
ARTICLE | Distillery Therapeutics

Inflammation; infectious disease

February 13, 2018 4:49 PM UTC

In vitro and mouse studies suggest inhibiting the MAC-1-CD40L interaction could help treat systemic inflammatory response syndrome (SIRS) and sepsis. In a mouse cell-based assay, a mAb against the M7 ...